Pharmaceutical

Tevimbra by BeiGene for Gallbladder Cancer: Likelihood of Approval

Tevimbra is under clinical development by BeiGene and currently in Phase II for Gallbladder Cancer.

Dec 31, 2024 - 06:00
Tevimbra is under clinical development by BeiGene and currently in Phase II for Gallbladder Cancer.
Read the original article

Tags:

Previous Article

Tevimbra by BeiGene for Muscle Invasive Bladder Cancer (MIBC): Likelihood of App...

Next Article

Iptacopan hydrochloride by Novartis for Granulomatosis with Polyangiitis (Wegene...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Sen. Bernie Sanders publicly pressures Merck, J&J, and Bristol Myers Squibb to testify on drug pricing

STAT+: Sen. Bernie Sanders publicly pressures Merck, J&...

Nov 21, 2023

STAT+: Key senators blast Medicare Advantage insurers for ‘exorbitant salaries,’ ‘massive payouts’ to execs

STAT+: Key senators blast Medicare Advantage insurers f...

Mar 24, 2023

Genentech review of Tessier-Lavigne paper finds no evidence of fraud — but hints at a different misconduct case

Genentech review of Tessier-Lavigne paper finds no evid...

Apr 7, 2023